Revixon® — Redefining Neuropathy Support

Misk Pharma proudly introduces Revixon®, a novel, first-of-its-kind nutraceutical formulation setting a new benchmark in peripheral neuropathy management.

Developed through advanced pharmaceutical formulation technologies, Revixon® delivers a unique, multi-targeted approach in a single, optimized capsule. For the first time globally, Cytidine, Uridine, and Alpha-Lipoic Acid are combined in one formulation to provide comprehensive nutritional support for nerve health and functional recovery.

More than a product, Revixon® is a market-defining innovation designed to address unmet needs through clear differentiation, scientific rationale, and improved patient convenience. By integrating key ingredients into one daily dosage form, Revixon® supports better adherence while empowering healthcare professionals with a modern, science-driven solution.

With Revixon®, Misk Pharma reinforces its commitment to premium, high-value innovation and its ambition to compete on a global stage—delivering world-class solutions that elevate standards in neuropathy support.